Skip to main content
Log in

A polymorphism in the angiogenesis inhibitor, endostatin, in sporadic colorectal adenocarcinoma

  • Letter to the Editor
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Reference

  1. Iughetti P, Suzuki O, Godoi PH, et al (2001) A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma. Cancer Res 61:7375–7378

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carmen Silvia Passos Lima.

Additional information

This study was supported financially by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nascimento, H., Rodrigues Coy, C.S., Navarro Góes, J.R. et al. A polymorphism in the angiogenesis inhibitor, endostatin, in sporadic colorectal adenocarcinoma. Int J Colorectal Dis 19, 499–501 (2004). https://doi.org/10.1007/s00384-004-0590-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-004-0590-8

Keywords

Navigation